{"title":"Acreditación de entrevistas individualizadas con los facultativos de Atención Primaria","authors":"R. Fernández Urrusuno, M.C. Montero Balosa","doi":"10.1016/S2172-3761(11)70028-0","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70028-0","url":null,"abstract":"<div><p>One of the activities carried out by Primary Care pharmacists aimed at improving prescription quality is a face-to-face interview with the medical professionals.</p><p>Accreditation of these interviews as a training activity provides added value for the professional interviewed and for the pharmacist, in regards to incorporation of a structured methodology, establishment of the objectives agreed on, commitment for mutual collaboration and periodic follow-up of the prescription profile.</p><p>This methodology motivates the professional to improve the prescription profile since it puts it into a clinical context frame and not a purely management one.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 2","pages":"Pages 54-57"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70028-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71829090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Márquez Ferrando , B. Fernández-Lobato , V. Arroyo Pineda
{"title":"La gastrolesividad de los AINE no solo depende del principio activo sino de su farmacocinética y farmacodinamia","authors":"M. Márquez Ferrando , B. Fernández-Lobato , V. Arroyo Pineda","doi":"10.1016/S2172-3761(11)70030-9","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70030-9","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 2","pages":"64-65"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70030-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71719453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. García Robredo , E. Candela Marroquín , C. Barreda Velázquez
{"title":"La reducción del colesterol con rosuvastatina no frena la progresión de la estenosis aórtica","authors":"B. García Robredo , E. Candela Marroquín , C. Barreda Velázquez","doi":"10.1016/S2172-3761(11)70021-8","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70021-8","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 1","pages":"28-30"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70021-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71739316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Suárez Alemán, C. Fernández Oropesa, E. Hevia Álvarez
{"title":"Riesgo cardiovascular y mortalidad asociada a los antidiabéticos orales: un estudio observacional con limitaciones que no modifica las recomendaciones actuales","authors":"C. Suárez Alemán, C. Fernández Oropesa, E. Hevia Álvarez","doi":"10.1016/S2172-3761(11)70022-X","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70022-X","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 1","pages":"30-31"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70022-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71739317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A.A. Iglesias-Iglesias , M. Rovira-Vila , N. Izko-Gartzia , O. Pérez-Rodríguez , R.M. Rodríguez-Rincón , L. Álvarez-Arroyo
{"title":"Suministro de medicamentos desde hospitales a centros de Atención Primaria y gestión de la calidad","authors":"A.A. Iglesias-Iglesias , M. Rovira-Vila , N. Izko-Gartzia , O. Pérez-Rodríguez , R.M. Rodríguez-Rincón , L. Álvarez-Arroyo","doi":"10.1016/S2172-3761(11)70014-0","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70014-0","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 1","pages":"15-19"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70014-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71823477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Conclusiones del contenido científico del XV Congreso Nacional de la SEFAP","authors":"MaC. Celaya Lecea , M.C. Labarta Mancho , M.M. Aza Pascual-Salcedo , M. Elfau Mairal , M.J. Lallana Álvarez","doi":"10.1016/S2172-3761(11)70023-1","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70023-1","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 1","pages":"Pages 32-33"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70023-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71739318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"La Sociedad estrena su primer plan estratégico","authors":"Arantxa Catalán","doi":"10.1016/S2172-3761(11)70011-5","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70011-5","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 1","pages":"Page 1"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70011-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71820043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Rodríguez Castilla, R. Fernández Urrusuno, I. Ferrer López
{"title":"Menos exacerbaciones asmáticas en los niños usando corticoides inhalados en vez de montelukast","authors":"J. Rodríguez Castilla, R. Fernández Urrusuno, I. Ferrer López","doi":"10.1016/S2172-3761(11)70017-6","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70017-6","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 1","pages":"23-24"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70017-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71823461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medicamentos biotecnológicos; from dream to reality","authors":"S. Ruiz , E. Sulleiro , G. Calvo","doi":"10.1016/S2172-3761(11)70040-1","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70040-1","url":null,"abstract":"<div><p>In the last 20 years, biotechnological medicinal products have had an increasing role in the treatment of many conditions. These products have several advantages over other biological medicinal products such as potential availability in large quantities, an excellent safety record regarding transmission of viruses or other pathogens and the possibility to have modified molecules or combinations of parts from different molecules to achieve a different specificity or affinity, pharmacokinetic profile or reduced immunogenicity. Biotech medicines are mainly for hospital use and the impact of their introduction is determined by some of their characteristics such as large availability and specificity. However, in some cases, high expectations about their efficacy have not been reached and even their benefit can be questioned considering the toxicity associated with their use. The production process and control of biotech medicines is expensive and complex, therefore, their high price and widespread use is increasingly challenging for healthcare systems.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 3","pages":"Pages 85-88"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70040-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71828410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. López-Palomino, R. Seisdedos-Elcuaz, R.M. Ramos-Guerrero, F. Forja-Pajares, M. Márquez-Ferrando
{"title":"Implantación de un programa sistemático de revisión de prescripciones electrónicas","authors":"J. López-Palomino, R. Seisdedos-Elcuaz, R.M. Ramos-Guerrero, F. Forja-Pajares, M. Márquez-Ferrando","doi":"10.1016/S2172-3761(11)70026-7","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70026-7","url":null,"abstract":"<div><h3>Objective</h3><p>To implement a systematic review of electronic prescriptions with a view to promoting the safe and efficient use of drugs.</p></div><div><h3>Materials and method</h3><p>This scheme was introduced in May 2010 in a Primary Healthcare District serving a population of approximately half a million inhabitants, and involved the analysis and close monitoring of the electronic prescriptions generated by general practitioners. All patients receiving electronic prescriptions were included in the study, and priority was given to patients on multiple medication. From its very inception the project was considered crucial to improving the safe and efficient use of prescription drugs, and was designed and promoted by the Directors of the Primary Healthcare District and by the members of its Pharmacy Department, with monitoring provided by the Directors of each Primary Healthcare Centre. To measure its impact, we employed the following as monitoring indicators: estimated annual cost/TAFE and estimated annual number of prescriptions/TAFE. TAFE relates to the individual healthcare card weighted in accordance with the age of the user and his or her related pharmaceutical cost.</p></div><div><h3>Results</h3><p>The original aim was successfully achieved, and is reflected in the large number of patients reviewed, in a decrease in the estimated annual number of prescriptions, and, consequently, in the corresponding pharmaceutical cost.</p></div><div><h3>Conclusion</h3><p>Electronic prescribing is an important tool in developing more effective management of the general practitioner clinic, but failure by the physician to monitor prescribed treatments over prolonged periods leads to the inappropriate use of therapeutic resources and, to avoid this, it is essential to implement strategies such as the one described.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 2","pages":"Pages 42-45"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70026-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71828668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}